AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Use these Linux commands to quickly search and find anything from the Linux terminal, without digging through folders in a GUI file manager.

A python sparked panic when it was seen slithering across a shop roof. Horrified shoppers noticed the reptile coiled along ...

This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...

An attack campaign undertaken by a Vietnam-aligned hacking group known as OceanLotus (aka APT-Q-31) that delivers the Havoc post-exploitation framework in attacks targeting enterprises and government ...

This paper describes Unbend - a new method for measuring and correcting motions in cryo-EM images, with a particular emphasis on more challenging in situ samples such as lamella and whole cells. The ...

Putting an exception like that aside, anyhow, this is a singer/songwriter record in the classic sense. “Returning to Myself” in this case involves sort of returning to the 1970s, a little bit, when ...